{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:12:56Z","timestamp":1787242376340,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12185-024-03912-y","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T05:31:46Z","timestamp":1736487106000},"page":"622-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 3: solid cancers and vascular abnormalities"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6220-8657","authenticated-orcid":false,"given":"Yoshinobu","family":"Seki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Madoiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidesaku","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Uchiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Gando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kushimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineji","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Mayumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Committee of the Clinical Practice Guidelines for Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis and Hemostasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"3912_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/0004084672","volume":"49","author":"N Kobayashi","year":"1983","unstructured":"Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibl Haematol. 1983;49:265\u201375. https:\/\/doi.org\/10.1159\/0004084672.","journal-title":"Bibl Haematol"},{"key":"3912_CR2","doi-asserted-by":"crossref","unstructured":"Aoki N, Hasegawa A (1988) Ministry of Health and Welfare, Research Group for investigation of blood coagulation disorders of specific diseases. 1987 Performance Report Collection, pp 37\u201341 (in Japanese)","DOI":"10.1007\/978-3-642-83098-3_3"},{"key":"3912_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","volume":"34","author":"S Gando","year":"2006","unstructured":"Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34:625\u201331.","journal-title":"Crit Care Med"},{"key":"3912_CR4","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor","year":"2001","unstructured":"Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327\u201330.","journal-title":"Thromb Haemost"},{"key":"3912_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2052-0492-2-20","volume":"2","author":"H Asakura","year":"2014","unstructured":"Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care. 2014;2:20.","journal-title":"J Intensive Care"},{"key":"3912_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ajh.2830330204","volume":"33","author":"H Takahashi","year":"1990","unstructured":"Takahashi H, Tatewaki W, Wada K, Hanano M, Shibata A. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol. 1990;33:90\u20135. https:\/\/doi.org\/10.1002\/ajh.2830330204.","journal-title":"Am J Hematol"},{"key":"3912_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12959-016-0117-x","volume":"14","author":"H Asakura","year":"2016","unstructured":"Asakura H, Takahashi H, Uchiyama T, Eguchi Y, Okamoto K, Kawasugi K, DIC subcommittee of the Japanese Society on Thrombosis and Hemostasis, et al. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016;14:42.","journal-title":"Thromb J"},{"key":"3912_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12959-016-0117-x","volume":"15","author":"H Wada","year":"2017","unstructured":"Wada H, Takahashi H, Uchiyama T, Eguchi Y, Okamoto K, Kawasugi K, et al. Proposal for revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2017;15:17. https:\/\/doi.org\/10.1186\/s12959-016-0117-x.","journal-title":"Thromb J"},{"key":"3912_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1177\/1076029616672582","volume":"23","author":"T Aota","year":"2017","unstructured":"Aota T, Wada H, Fujimoto N, Yamashita Y, Matsumoto T, Ohishi K, et al. Evaluation of the diagnostic criteria for the basic type of DIC established by the Japanese Society of Thrombosis and Hemostasis. Clin Appl Thromb Hemost. 2017;23:838\u201343. https:\/\/doi.org\/10.1177\/1076029616672582.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3912_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1155\/2022\/2226761","volume":"Article ID 2226","author":"N Omidkhoda","year":"2022","unstructured":"Omidkhoda N, Abedi F, Ghavami V, Rahimi H, Samadi S, Arasteh O, et al. The effect of heparin and its preparations on disseminated intravascular coagulation mortality and hospitalization: a systematic review. Int J Clin Pract. 2022;Article ID 2226761:9. https:\/\/doi.org\/10.1155\/2022\/2226761.","journal-title":"Int J Clin Pract"},{"key":"3912_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0049-3848(93)90109-2","volume":"72","author":"N Sakuragawa","year":"1993","unstructured":"Sakuragawa N, Hasegawa H, Maki M, Nakagawa M, Nakashima M. Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)\u2014a multicenter co-operative double-blind trial in comparison with heparin. Throm Res. 1993;72:475\u2013500. https:\/\/doi.org\/10.1016\/0049-3848(93)90109-2.","journal-title":"Throm Res"},{"key":"3912_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1155\/2022\/2226761","volume":"17","author":"JM Wen","year":"2018","unstructured":"Wen JM, Sun JX, Pan XH, Chen HS. Effects of low-molecular-weight heparin and unfractionated heparin on traumatic disseminated intravascular coagulation. Trop J Pharm Res. 2018;17:961\u20136. https:\/\/doi.org\/10.1155\/2022\/2226761.","journal-title":"Trop J Pharm Res"},{"key":"3912_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF00444754","volume":"133","author":"U G\u00f6bel","year":"1980","unstructured":"G\u00f6bel U, Voss H, J\u00fcrgens H, Petrich C, Pothmann R, Sprock I, et al. Efficiency of heparin in the treatment of newborn infants with respiratory distress syndrome and disseminated intravascular coagulation. Eur J Pediatr. 1980;133:47\u20139. https:\/\/doi.org\/10.1007\/BF00444754.","journal-title":"Eur J Pediatr"},{"key":"3912_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094\u20139. https:\/\/doi.org\/10.1111\/jth.14817.","journal-title":"J Thromb Haemost"},{"key":"3912_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3892\/mco.2021.2266","volume":"14","author":"T Yagi","year":"2021","unstructured":"Yagi T, Nakamura H, Wakamatsu T, Imura Y, Tamiya H, Sabe H, et al. Primary breast angiosarcoma with disseminated intravascular coagulation is successfully treated with self-subcutaneous unfractionated heparin calcium injection: a case report. Mol Clin Oncol. 2021;14:104. https:\/\/doi.org\/10.3892\/mco.2021.2266. (Epub 2021 Mar 17).","journal-title":"Mol Clin Oncol"},{"key":"3912_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10147-014-0768-1","volume":"20","author":"K Tamura","year":"2015","unstructured":"Tamura K, Saito H, Asakura H, Okamoto K, Tagawa J, Hayakawa T, et al. Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial. Int J Clin Oncol. 2015;20:821\u20138. https:\/\/doi.org\/10.1007\/s10147-014-0768-1.","journal-title":"Int J Clin Oncol"},{"key":"3912_CR17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s10147-018-1261-z","volume":"23","author":"K Ouchi","year":"2018","unstructured":"Ouchi K, Takahashi S, Chikamatsu S, Ito S, Takahashi Y, Kawai S, et al. Retrospective analysis of the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors. Int J Clin Oncol. 2018;23:790\u20138. https:\/\/doi.org\/10.1007\/s10147-018-1261-z.","journal-title":"Int J Clin Oncol"},{"key":"3912_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1055\/s-0040-1715840","volume":"121","author":"K Taniguchi","year":"2021","unstructured":"Taniguchi K, Ohbe H, Yamakawa K, Matsui H, Fushimi K, Yasunaga H. Recombinant thrombomodulin in disseminated intravascular coagulation associated with stage IV solid tumors: a nationwide observational study in Japan. Thromb Haemost. 2021;121:36\u201345. https:\/\/doi.org\/10.1055\/s-0040-1715840.","journal-title":"Thromb Haemost"},{"issue":"12","key":"3912_CR19","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1111\/j.1538-7836.2006.02267.x","volume":"41","author":"Y Asano","year":"2014","unstructured":"Asano Y, Kashiwagi S, Shibutani M, Yamazoe S, Noda S, Sakurai K, et al. Effect of recombinant human soluble thrombomodulin in patients with solid carcinoma with dic. Gan To Kagaku Ryoho. 2014;41(12):2503\u20135. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02267.x.","journal-title":"Gan To Kagaku Ryoho"},{"key":"3912_CR20","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1097\/00003246-200005000-00027","volume":"28","author":"T Nishiyama","year":"2000","unstructured":"Nishiyama T, Matsukawa T, Hanaoka K. Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation? Crit Care Med. 2000;28:1419\u201322. https:\/\/doi.org\/10.1097\/00003246-200005000-00027.","journal-title":"Crit Care Med"},{"key":"3912_CR21","first-page":"678","volume":"103","author":"JT Hsu","year":"2004","unstructured":"Hsu JT, Chen HM, Chiu DF, Chen JC, Huang CJ, Hwang TL, et al. Efficacy of gabexate mesilate on disseminated intravascular coagulation as a complication of infection developing after abdominal surgery. J Formos Med Assoc. 2004;103:678\u201384.","journal-title":"J Formos Med Assoc"},{"key":"3912_CR22","first-page":"144","volume":"124","author":"G Kosaki","year":"1983","unstructured":"Kosaki G, Kamihayashi J, Hirayama A, Mori K, Uchida T, Abe S, et al. Study on therapeutic efficacy of FOY for DIC\u2014multicenter comparative clinical trial. Igakunoayumi. 1983;124:144\u201354 (in Japanese).","journal-title":"Igakunoayumi"},{"key":"3912_CR23","first-page":"921","volume":"65","author":"A Shibata","year":"1988","unstructured":"Shibata A, Takahashi H, Aoki N, Matsuda T, Yasunaga K, Kondo M, et al. Therapeutic efficacy of FUT-175 injection for DIC\u2014a multicenter comparative clinical study. Rinshotokenkyu. 1988;65:921\u201340 (in Japanese).","journal-title":"Rinshotokenkyu"},{"key":"3912_CR24","unstructured":"Iba T, Kidokoro A. Disseminated intravascular coagulation. Nihon Rinsho. 2003;61(6):1010\u20134. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12806952."},{"issue":"8","key":"3912_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1182\/blood-2017-10-804096","volume":"131","author":"M Levi","year":"2018","unstructured":"Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131(8):845\u201354. https:\/\/doi.org\/10.1182\/blood-2017-10-804096.","journal-title":"Blood"},{"issue":"1","key":"3912_CR26","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1186\/s12885-020-07375-2","volume":"20","author":"K Taniguchi","year":"2020","unstructured":"Taniguchi K, Ohbe H, Yamakawa K, Matsui H, Fushimi K, Yasunaga H, et al. Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan. BMC Cancer. 2020;20(1):867. https:\/\/doi.org\/10.1186\/s12885-020-07375-2.","journal-title":"BMC Cancer"},{"issue":"3","key":"3912_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00001721-199804000-00010","volume":"9","author":"K Meijer","year":"1998","unstructured":"Meijer K, Smid WM, Geerards S, Meer J. Hyperfibrinogenolysis in disseminated adenocarcinoma. Blood Coagul Fibrinolysis. 1998;9(3):279\u201383. https:\/\/doi.org\/10.1097\/00001721-199804000-00010.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"34\u201335","key":"3912_CR28","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1055\/s-0032-1305227","volume":"137","author":"M Orgel","year":"2012","unstructured":"Orgel M, Horger M, Kurth R, Kanz L, Jaschonek K, Mayer F, et al. Severe hemorrhage in a patient with metastatic colorectal cancer\u2014case 8\/2012. Dtsch Med Wochenschr. 2012;137(34\u201335):1705. https:\/\/doi.org\/10.1055\/s-0032-1305227. (in German).","journal-title":"Dtsch Med Wochenschr"},{"key":"3912_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/1752-1947-6-378","volume":"6","author":"Y Wada","year":"2012","unstructured":"Wada Y, Uchiba M, Kawano Y, Kai N, Takahashi W, Honda J, et al. Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report. J Med Case Rep. 2012;6:378. https:\/\/doi.org\/10.1186\/1752-1947-6-378.","journal-title":"J Med Case Rep"},{"key":"3912_CR30","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2022.0249","author":"S Yamada","year":"2022","unstructured":"Yamada S, Suga Y, Morishita E, Asakura H. Effect of anticoagulant\/antifibrinolytic combination therapy on enhanced fibrinolytic-type disseminated intravascular coagulation in end-of-life stage solid tumor patients. J Palliat Med. 2022. https:\/\/doi.org\/10.1089\/jpm.2022.0249.","journal-title":"J Palliat Med"},{"issue":"12","key":"3912_CR31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.428","volume":"7","author":"O Prokopchuk-Gauk","year":"2015","unstructured":"Prokopchuk-Gauk O, Brose K. Tranexamic acid to treat life-threatening hemorrhage in prostate cancer associated disseminated intravascular coagulation with excessive fibrinolysis. Cureus. 2015;7(12): e428. https:\/\/doi.org\/10.7759\/cureus.428.","journal-title":"Cureus"},{"issue":"Suppl 1","key":"3912_CR32","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/s0049-3848(02)00146-9","volume":"107","author":"MM Mueller","year":"2002","unstructured":"Mueller MM, Bomke B, Seifried E. Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases. Thromb Res. 2002;107(Suppl 1):S9-17. https:\/\/doi.org\/10.1016\/s0049-3848(02)00146-9.","journal-title":"Thromb Res"},{"key":"3912_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.beha.2005.01.027","volume":"19","author":"M Levi","year":"2006","unstructured":"Levi M, de Jonge E, van der Poll T. Plasma and plasma components in the management of disseminated intravascular coagulation. Best Pract Res Clin Haematol. 2006;19:127\u201342. https:\/\/doi.org\/10.1016\/j.beha.2005.01.027.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"3912_CR34","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1160\/TH15-09-0740","volume":"115","author":"A Squizzato","year":"2016","unstructured":"Squizzato A, Hunt BJ, Kinasewitz GT, Wada H, Cate HT, Thachil J, et al. Supportive management strategies for disseminated intravascular coagulation. An international consensus. Thromb Haemost. 2016;115(5):896\u2013904. https:\/\/doi.org\/10.1160\/TH15-09-0740.","journal-title":"Thromb Haemost"},{"key":"3912_CR35","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/jth.12155","volume":"11","author":"H Wada","year":"2013","unstructured":"Wada H, Thachil J, Di Nisio M, Mathew P, Kurosawa S, Gando S, the Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013;11:761\u20137. https:\/\/doi.org\/10.1111\/jth.12155.","journal-title":"J Thromb Haemost"},{"key":"3912_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/jth.12838","volume":"13","author":"J Thachil","year":"2015","unstructured":"Thachil J, Falanga A, Levi M, Liebman H, Di Nisio M. Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost. 2015;13:671\u20135. https:\/\/doi.org\/10.1111\/jth.12838.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"3912_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.thromres.2009.08.017","volume":"125","author":"H Wada","year":"2010","unstructured":"Wada H, Asakura H, Okamoto K, Iba T, Uchiyama T, Kawasugi K, Japanese Society of Thrombosis Hemostasis\/DIC subcommittee, et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res. 2010;125(1):6\u201311. https:\/\/doi.org\/10.1016\/j.thromres.2009.08.017.","journal-title":"Thromb Res"},{"issue":"9","key":"3912_CR38","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","volume":"125","author":"R Goel","year":"2015","unstructured":"Goel R, Ness PM, Takemoto CM, Lakshmanan Krishnamurti L, King KE, Tobian AAR. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood. 2015;125(9):1470\u20136. https:\/\/doi.org\/10.1182\/blood-2014-10-605493.","journal-title":"Blood"},{"issue":"8","key":"3912_CR39","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJM199908193410807","volume":"341","author":"M Levi","year":"1999","unstructured":"Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341(8):586\u201392. https:\/\/doi.org\/10.1056\/NEJM199908193410807.","journal-title":"N Engl J Med"},{"issue":"11","key":"3912_CR40","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/archsurg.1983.01390110010002","volume":"118","author":"DF Fisher Jr","year":"1983","unstructured":"Fisher DF Jr, Yawn DH, Crawford ES. Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases. Arch Surg. 1983;118(11):1252\u20135. https:\/\/doi.org\/10.1001\/archsurg.1983.01390110010002.","journal-title":"Arch Surg"},{"issue":"5","key":"3912_CR41","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ejvs.2016.02.009","volume":"51","author":"A Kordzadeh","year":"2016","unstructured":"Kordzadeh A, Parsa AD, Askari A, Maddison B, Panayiotopoulos YP. Presenting baseline coagulation of infra renal ruptured abdominal aortic aneurysm: a systematic review and pooled analysis. Eur J Vasc Endovasc Surg. 2016;51(5):682\u20139. https:\/\/doi.org\/10.1016\/j.ejvs.2016.02.009.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"3912_CR42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1046\/j.1365-2141.2001.02453.x","volume":"112","author":"GW Hall","year":"2001","unstructured":"Hall GW. Kasabach\u2013Merritt syndrome: pathogenesis and management. Br J Haematol. 2001;112(4):851\u201362. https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02453.x.","journal-title":"Br J Haematol"},{"issue":"Suppl","key":"3912_CR43","first-page":"Ecr29","volume":"90","author":"Y Ontachi","year":"2005","unstructured":"Ontachi Y, Asakura H, Omote M, Yoshida T, Matsui O, Nakao S. Kasabach\u2013Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. Haematologica. 2005;90(Suppl):Ecr29.","journal-title":"Haematologica"},{"issue":"3","key":"3912_CR44","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3400\/avd.cr.20-00148","volume":"14","author":"S Yamada","year":"2021","unstructured":"Yamada S, Arahata M, Morishita E, Asakura H. Blue rubber bleb nevus syndrome complicated by enhanced-fibrinolytic-type DIC: a case report. Ann Vasc Dis. 2021;14(3):252\u20135. https:\/\/doi.org\/10.3400\/avd.cr.20-00148.","journal-title":"Ann Vasc Dis"},{"issue":"3","key":"3912_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/000331979704800312","volume":"48","author":"M Kunishige","year":"1997","unstructured":"Kunishige M, Azuma H, Masuda K, Shigekiyo T, Arii Y, Kawai H, et al. Interferon alpha-2a therapy for disseminated intravascular coagulation in a patient with blue rubber bleb nevus syndrome. A case report. Angiology. 1997;48(3):273\u20137. https:\/\/doi.org\/10.1177\/000331979704800312.","journal-title":"Angiology"},{"issue":"7","key":"3912_CR46","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/MBC.0b013e3283626238","volume":"24","author":"E Randrianarisoa","year":"2013","unstructured":"Randrianarisoa E, Kopp HG, Balletshofer BM, Jaschonek K, Kanz L, Haering HU, et al. Management of disseminated intravascular coagulopathy with direct factor Xa inhibitor rivaroxaban in Klippel-Tr\u00e9naunay syndrome. Blood Coagul Fibrinolysis. 2013;24(7):766\u201370. https:\/\/doi.org\/10.1097\/MBC.0b013e3283626238.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"3912_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/mrcr\/rxac078","volume":"7","author":"N Yilmaz","year":"2023","unstructured":"Yilmaz N, Goksoy HS, Sever IH, Yavuz S. Chronic disseminated intravascular coagulation in a patient with Takayasu arteritis. Mod Rheumatol Case Rep. 2023;7(1):138\u201341. https:\/\/doi.org\/10.1093\/mrcr\/rxac078.","journal-title":"Mod Rheumatol Case Rep"},{"issue":"6","key":"3912_CR48","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/ndt\/13.6.1553","volume":"13","author":"S Lal","year":"1998","unstructured":"Lal S, Sim E, Harty J, Singhal S, Baaj FA, Wardman A, et al. Disseminated intravascular coagulation complicating polyarteritis nodosa in alpha-1-antitrypsin deficiency. Nephrol Dial Transplant. 1998;13(6):1553\u20135. https:\/\/doi.org\/10.1093\/ndt\/13.6.1553.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"3912_CR49","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/0009922809356468","volume":"49","author":"SH Lee","year":"2010","unstructured":"Lee SH, Jeon YH, Yang HJ, Pyun BY. Pleural effusion and disseminated intravascular coagulopathy: the rarely reported complications of Kawasaki disease. Clin Pediatr (Phila). 2010;49(6):598\u2013600. https:\/\/doi.org\/10.1177\/0009922809356468.","journal-title":"Clin Pediatr (Phila)"},{"issue":"9","key":"3912_CR50","doi-asserted-by":"publisher","first-page":"850","DOI":"10.2169\/internalmedicine.42.850","volume":"42","author":"T Saito","year":"2003","unstructured":"Saito T, Tsuchiya M, Shikata C, Yamaguchi H, Miyata S, Matsuo S, et al. Microscopic polyangiitis associated with marked systemic bleeding tendency caused by disseminated intravascular coagulation. Intern Med. 2003;42(9):850\u20135. https:\/\/doi.org\/10.2169\/internalmedicine.42.850.","journal-title":"Intern Med"},{"issue":"6","key":"3912_CR51","first-page":"671","volume":"15","author":"T Kogure","year":"1997","unstructured":"Kogure T, Fujinaga H, Nozaki K, Sakai S, Itoh T, Terasawa K. Systemic lupus erythematosus complicated by disseminated intravascular coagulation: the role of serum soluble cell surface markers. Clin Exp Rheumatol. 1997;15(6):671\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"3912_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.51.3.347","volume":"51","author":"D Schwartz","year":"1992","unstructured":"Schwartz D, Averbuch M, Pines A, Kornovsky R, Levo Y. Disseminated intravascular coagulation with renal and liver damage as the predominant manifestations of recurrent relapses in systemic juvenile rheumatoid arthritis. Ann Rheum Dis. 1992;51(3):347\u20139. https:\/\/doi.org\/10.1136\/ard.51.3.347.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3912_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2052-0492-2-15","volume":"2","author":"H Wada","year":"2014","unstructured":"Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care. 2014;2(1):15. https:\/\/doi.org\/10.1186\/2052-0492-2-15.","journal-title":"J Intensive Care"},{"issue":"1","key":"3912_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12185-020-03028-z","volume":"113","author":"S Yamada","year":"2021","unstructured":"Yamada S, Asakura H. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations. Int J Hematol. 2021;113(1):15\u201323. https:\/\/doi.org\/10.1007\/s12185-020-03028-z.","journal-title":"Int J Hematol"},{"key":"3912_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031296","author":"S Yamada","year":"2022","unstructured":"Yamada S, Asakura H. Therapeutic strategies for disseminated intravascular coagulation associated with aortic aneurysm. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23031296.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3912_CR56","doi-asserted-by":"publisher","first-page":"158","DOI":"10.7326\/L14-5014-3","volume":"161","author":"T Hayashi","year":"2014","unstructured":"Hayashi T, Nakagawa N, Kadohira Y, Morishita E, Asakura H. Rivaroxaban in a patient with disseminated intravascular coagulation associated with an aortic aneurysm: a case report. Ann Intern Med. 2014;161(2):158\u20139. https:\/\/doi.org\/10.7326\/L14-5014-3.","journal-title":"Ann Intern Med"},{"issue":"8","key":"3912_CR57","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/MBC.0000000000000666","volume":"28","author":"A Yasumoto","year":"2017","unstructured":"Yasumoto A, Ishiura R, Narushima M, Yatomi Y. Successful treatment with dabigatran for consumptive coagulopathy associated with extensive vascular malformations. Blood Coagul Fibrinolysis. 2017;28(8):670\u20134. https:\/\/doi.org\/10.1097\/MBC.0000000000000666.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"3912_CR58","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jvsv.2022.09.015","volume":"11","author":"H Liu","year":"2023","unstructured":"Liu H, Hu L, Yang X, Xu Z, Gu H, Chen H, et al. Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations. J Vasc Surg Venous Lymphat Disord. 2023;11(2):397-403.e1. https:\/\/doi.org\/10.1016\/j.jvsv.2022.09.015.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"20","key":"3912_CR59","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.2169\/internalmedicine.54.4942","volume":"54","author":"H Kawano","year":"2015","unstructured":"Kawano H, Hata T, Uda A, Maemura K. Use of rivaroxaban for the effective management of disseminated intravascular coagulation associated with abdominal aortic aneurysm. Intern Med. 2015;54(20):2625\u20138. https:\/\/doi.org\/10.2169\/internalmedicine.54.4942.","journal-title":"Intern Med"},{"issue":"21","key":"3912_CR60","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.2169\/internalmedicine.8666-16","volume":"56","author":"Y Kadohira","year":"2017","unstructured":"Kadohira Y, Yamada S, Matsuura E, Hayashi T, Morishita E, Nakao S, et al. Aortic aneurysm-associated disseminated intravascular coagulation that responded well to a switch from warfarin to rivaroxaban. Intern Med. 2017;56(21):2913\u20137. https:\/\/doi.org\/10.2169\/internalmedicine.8666-16.","journal-title":"Intern Med"},{"issue":"3","key":"3912_CR61","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1055\/s-0038-1675386","volume":"39","author":"S Janjetovic","year":"2019","unstructured":"Janjetovic S, Holstein K, Dicke C, Bokemeyer C, Florian LF. Apixaban for the treatment of chronic disseminated intravascular coagulation: a report of two cases. Hamostaseologie. 2019;39(3):294\u20137. https:\/\/doi.org\/10.1055\/s-0038-1675386.","journal-title":"Hamostaseologie"},{"issue":"16","key":"3912_CR62","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2169\/internalmedicine.4255-19","volume":"59","author":"S Uemura","year":"2020","unstructured":"Uemura S, Kobayashi H, Seki Y, Yuki Okoshi Y, Sone H, Nomoto N. Successful treatment with edoxaban for disseminated intravascular coagulation in a case of aortic dissection complicated with immune thrombocytopenic purpura. Intern Med. 2020;59(16):2035\u20139. https:\/\/doi.org\/10.2169\/internalmedicine.4255-19.","journal-title":"Intern Med"},{"issue":"4","key":"3912_CR63","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/MBC.0000000000000902","volume":"31","author":"S Yamada","year":"2020","unstructured":"Yamada S, Okumura H, Morishita E, Asakura H. Complete hemostasis achieved by factor XIII concentrate administration in a patient with bleeding after teeth extraction as a complication of aplastic anemia and chronic disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2020;31(4):274\u20138. https:\/\/doi.org\/10.1097\/MBC.0000000000000902.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3912_CR64","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.wneu.2019.05.089","volume":"128","author":"E Tsukamoto","year":"2019","unstructured":"Tsukamoto E, Tanei T, Kato T, Naito T, Torii J, Ishii K, et al. Repeated intracranial hemorrhage after delivery induced by coagulopathy associated with multiple venous malformations. World Neurosurg. 2019;128:434\u20137.","journal-title":"World Neurosurg"},{"issue":"20","key":"3912_CR65","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1056\/NEJM196905152802006","volume":"280","author":"C Charytan","year":"1969","unstructured":"Charytan C, Purtilo D. Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med. 1969;280(20):1102\u20134. https:\/\/doi.org\/10.1056\/NEJM196905152802006.","journal-title":"N Engl J Med"},{"key":"3912_CR66","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/icvts\/ivv117","volume":"21","author":"T Uzuka","year":"2015","unstructured":"Uzuka T, Nakamura M, Kuroda Y, Watanabe N. The use of an antifibrinolytic agent to reduce endoleak following endovascular repair of multiple aortic aneurysms. Interact Cardiovasc Thorac Surg. 2015;21:266\u20138. https:\/\/doi.org\/10.1093\/icvts\/ivv117.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"3912_CR67","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12959-022-00429-4","volume":"21","author":"N Suzuki","year":"2023","unstructured":"Suzuki N, Suzuki N, Kawaguchi Y, Okamoto S, Kanematsu T, Katsumi A, et al. The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients. Thromb J. 2023;21:10. https:\/\/doi.org\/10.1186\/s12959-022-00429-4.","journal-title":"Thromb J"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03912-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03912-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03912-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T06:48:33Z","timestamp":1745304513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03912-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3912"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03912-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yoshinobu Seki was involved in clinical trials conducted by Chugai and Takeda Pharmaceutical. Takayuki Ikezoe has received research grants from Asahi Kasei Pharma. Kazuma Yamakawa has received research grants from the Japan Blood Products Organization and Asahi Kasei Pharma. Takashi Ito has received lecture fees and research grants from Asahi Kasei Pharma. Toshiaki Iba received a research grant from JIMRO. Hiroyasu Ishikura has received lecture fees from Asahi Kasei Pharma. Hideo Wada received a research grant from I.L. Japan. Hidesaku Asakura is an editor of IJH. Other authors have any potential conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The questions and recommendations are summarized in Table\u00a0\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Recommendations and their rationales"}}]}}